SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-277126
Filing Date
2023-11-14
Accepted
2023-11-14 16:20:33
Documents
6
Effectiveness Date
2023-11-14

Document Format Files

Seq Description Document Type Size
1 S-8 d546131ds8.htm S-8 30862
2 EX-5.1 d546131dex51.htm EX-5.1 8098
3 EX-23.1 d546131dex231.htm EX-23.1 1540
4 EX-FILING FEES d546131dexfilingfees.htm EX-FILING FEES 14003
5 GRAPHIC g546131dsp7.jpg GRAPHIC 17777
6 GRAPHIC g546131dsp8.jpg GRAPHIC 6075
  Complete submission text file 0001193125-23-277126.txt   88573
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275547 | Film No.: 231406684
SIC: 2834 Pharmaceutical Preparations